ABC of AIDS. Antiretroviral drugs.
作者信息
Weller I V, Williams I G
出版信息
BMJ. 2001 Jun 9;322(7299):1410-2. doi: 10.1136/bmj.322.7299.1410.
Abstract
摘要
相似文献
1
ABC of AIDS. Antiretroviral drugs.艾滋病基础知识。抗逆转录病毒药物。
BMJ. 2001 Jun 9;322(7299):1410-2. doi: 10.1136/bmj.322.7299.1410.
2
Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy.
AIDS Res Hum Retroviruses. 2004 Aug;20(8):816-8. doi: 10.1089/0889222041725271.
3
Therapies. Confronting the limits of success.疗法。直面成功的局限。
Science. 2002 Jun 28;296(5577):2320-4. doi: 10.1126/science.296.5577.2320.
4
AIDS therapy. Failure isn't what it used to be...but neither is success.艾滋病治疗。失败已今非昔比……成功亦是如此。
Science. 1998 Feb 20;279(5354):1133-4. doi: 10.1126/science.279.5354.1133.
5
[Can HIV/AIDS be healed with new therapies?].[新型疗法能治愈艾滋病毒/艾滋病吗？]
Praxis (Bern 1994). 1997 May 28;86(22):931-2.
6
Improvement in CD4+ cell counts despite persistently detectable HIV load.尽管HIV载量持续可检测到，但CD4+细胞计数仍有所改善。
N Engl J Med. 1998 Apr 9;338(15):1074-5. doi: 10.1056/NEJM199804093381517.
7
[Study on the situation of antiretroviral therapy against HIV/AIDS in Henan province based on the CD4+ T cells count and virus load].基于CD4+T细胞计数和病毒载量的河南省艾滋病抗逆转录病毒治疗情况研究
Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Sep;31(9):1013-6.
8
[Antiretroviral therapy 1994 versus 2004. The reality illustrated by typical cases].[1994年与2004年的抗逆转录病毒疗法。典型病例所呈现的现实情况]
MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:72-3.
9
Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy.免疫缺陷作为接受联合抗逆转录病毒治疗的 HIV-1 感染患者中非艾滋病定义性恶性肿瘤的风险因素。
Clin Infect Dis. 2011 Jun 15;52(12):1458-65. doi: 10.1093/cid/cir207.
引用本文的文献
1
A survey of resistance mutations to reverse transcriptase inhibitors (RTIs) among HIV-1 patients in northeast of Iran.伊朗东北部HIV-1患者中逆转录酶抑制剂（RTIs）耐药突变的调查。
Mol Biol Res Commun. 2024;13(3):117-125. doi: 10.22099/mbrc.2024.48729.1895.
2
Association between Combination Antiretroviral Therapy and Telomere Length in People Living with Human Immunodeficiency Virus.抗逆转录病毒联合疗法与人类免疫缺陷病毒感染者端粒长度之间的关联
Biology (Basel). 2023 Sep 5;12(9):1210. doi: 10.3390/biology12091210.
3
Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation.新型2-（二苯基亚甲基）丙二酸衍生物作为抗HIV药物：分子建模、合成及生物学评价
Iran J Pharm Res. 2021 Dec 14;21(1):e123827. doi: 10.5812/ijpr.123827. eCollection 2022 Dec.
4
Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis.洛匹那韦-利托那韦联合疗法治疗住院COVID-19患者的疗效：一项荟萃分析。
Future Virol. 2021 Dec. doi: 10.2217/fvl-2021-0066. Epub 2022 Jan 31.
5
Novel Antiretroviral Therapeutic Strategies for HIV.新型抗 HIV 治疗策略。
Molecules. 2021 Aug 31;26(17):5305. doi: 10.3390/molecules26175305.
6
Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial.抗逆转录病毒治疗及其对乌干达5至7岁儿童口腔健康结局的影响：来自法国国家研究机构12174号随机试验的6年随访
Medicine (Baltimore). 2020 Sep 25;99(39):e22352. doi: 10.1097/MD.0000000000022352.
7
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.瑞德西韦、洛匹那韦/利托那韦和氯喹/羟氯喹影响新型 SARS-CoV-2 的抗病毒机制研究进展。
Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24.
8
Exogenous steroid-induced hypoadrenalism in a person living with HIV caused by a drug-drug interaction between cobicistat and intrabursal triamcinolone.由考比司他与囊内注射曲安奈德之间的药物相互作用导致的HIV感染者外源性类固醇诱导的肾上腺功能减退。
BMJ Case Rep. 2018 Dec 14;11(1):e226912. doi: 10.1136/bcr-2018-226912.
9
Tenofovir-induced renal tubular dysfunction among human immunodeficiency virus patients on antiretroviral therapy in Nigeria: Prospects for early detection of presymptomatic nephrotoxicity.尼日利亚接受抗逆转录病毒治疗的人类免疫缺陷病毒患者中替诺福韦诱导的肾小管功能障碍：早期检测症状前肾毒性的前景。
Kidney Res Clin Pract. 2018 Sep;37(3):230-238. doi: 10.23876/j.krcp.2018.37.3.230. Epub 2018 Sep 30.
10
Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy.骨髓干细胞用于清除循环中的HIV：一种假设的治疗策略。
J Biol Res (Thessalon). 2018 Feb 5;25:3. doi: 10.1186/s40709-018-0075-5. eCollection 2018 Dec.
Zotero 插件